502 results on '"Høyer-Hansen, Gunilla"'
Search Results
2. Supplementary data. Appendix 1. Members of The Danish Collaborative Research Group on Colorectal Cancer from The Prognostic and Predictive Value of Soluble Type IV Collagen in Colorectal Cancer: A Retrospective Multicenter Study
3. Supplemental Figure 1 - Standard curves from The Prognostic and Predictive Value of Soluble Type IV Collagen in Colorectal Cancer: A Retrospective Multicenter Study
4. CCR Translation on this Article from Cleaved Forms of the Urokinase Plasminogen Activator Receptor in Plasma Have Diagnostic Potential and Predict Postoperative Survival in Patients with Ovarian Cancer
5. Supplemental figure 2 - Linearity from The Prognostic and Predictive Value of Soluble Type IV Collagen in Colorectal Cancer: A Retrospective Multicenter Study
6. Data from TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases
7. Supplementary Figures from TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases
8. Supplementary Figure legends from TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases
9. Supplementary tables from TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases
10. Supplementary Table 1 from The Multifaceted Role of the Microenvironment in Liver Metastasis: Biology and Clinical Implications
11. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers
12. Targeting a Single Function of the Multifunctional Matrix Metalloprotease MT1-MMP: IMPACT ON LYMPHANGIOGENESIS
13. Plasma levels of intact and cleaved urokinase plasminogen activator receptor (uPAR) in men with clinically localised prostate cancer
14. Plasma Concentrations of Soluble Urokinase-Type Plasminogen Activator Receptor Are Increased in Patients with Malaria and Are Associated with a Poor Clinical or a Fatal Outcome
15. Urokinase Receptor Cleavage Correlates With Tumor Volume in a Transgenic Mouse Model of Breast Cancer
16. Experiments to Incorporate In — Vitro Synthesized Photosystem I Components into Thylakoids of the Barley Mutant viridis — zb 63
17. Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor
18. Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein
19. Circulating forms of urokinase-type plasminogen activator receptor in plasma can predict recurrence and survival in patients with urothelial carcinoma of the bladder
20. Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder
21. Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder
22. Urokinase-Type Plasminogen Activator, Its Receptor and Inhibitor as Biomarkers in Cancer
23. Reduced levels of soluble urokinase receptor (supar) fragment DII-III predicts venous ulcers that fail to heal: O28
24. Urokinase Receptor Variants in Tissue and Body Fluids
25. Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non-small cell lung cancer
26. Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation
27. The concentration of the cleaved suPAR forms in pre‐ and postoperative plasma samples improves the prediction of survival in colorectal cancer: A nationwide multicenter validation and discovery study
28. Crystal structure of the unoccupied murine urokinase‐type plasminogen activator receptor (uPAR) reveals a tightly packed DII–DIII unit
29. Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation
30. [13] Cellular receptor for urokinase-type plasminogen activator: Protein structure
31. Ligand binding modulates the structural dynamics and activity of urokinase-Type plasminogen activator:A possible mechanism of plasminogen activation
32. Ligand binding modulates the structural dynamics and activity of urokinase-type plasminogen activator: A possible mechanism of plasminogen activation
33. Antibody-Mediated Neutralization of uPA Proteolytic Function Reduces Disease Progression in Mouse Arthritis Models
34. The Use of Chloroplast Proteins in Crop Improvement
35. Monoclonal Antibodies to Chlorophyll α-protein 1 in Barley
36. Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab
37. The Prognostic and Predictive Value of Soluble Type IV Collagen in Colorectal Cancer:A Retrospective Multicenter Study
38. Tissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric Adenocarcinoma
39. Copenhagen uPAR prostate cancer (CuPCa) database:protocol and early results
40. Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab
41. Tissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric Adenocarcinoma
42. The Prognostic and Predictive Value of Soluble Type IV Collagen in Colorectal Cancer: A Retrospective Multicenter Study
43. Copenhagen uPAR prostate cancer (CuPCa) database: protocol and early results
44. uPAR Expression Pattern in Patients with Urothelial Carcinoma of the Bladder:Possible Clinical Implications
45. TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases
46. Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab
47. Urokinase receptor cleavage correlates with tumor volume in a transgenic mouse model of breast cancer
48. Circulating intact and cleaved forms of the urokinase-type plasminogen activator receptor:Biological variation, reference intervals and clinical useful cut-points
49. Su1782 - Upar(I) and type IV Collagen Outperform CEA as Prognostic Biomarker in Primary Colorectal Cancer
50. Probing in vitro translation products with monoclonal antibodies to chlorophylla/b-binding proteins of barley thylakoids
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.